COMPARATIVE ANALYSIS OF ANTI-INFLAMMATORY ACTIVITY OF AQUEOUS AND METHANOLIC EXTRACTS OF C. CASSIA AND C. ZEYLANICUM IN RAW264.7, SW1353 AND PRIMARY CHONDROCYTES

Authors

  • Prerna Raina Bharati Vidyapeeth University Medical College Campus
  • Cv. Chandrasekaran Natural Remedies Pvt. Ltd., Veersandra Industrial Area
  • Amit Aggarwal Natural Remedies Pvt. Ltd., Veersandra Industrial Area
  • Narendra Wagh Bharati Vidyapeeth University Medical College
  • Ruchika Kaul Ghanekar Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth University Medical College Campus, Dhankawadi, Pune 411043, India

Keywords:

C cassia, C zeylanicum, Inflammation, Osteoarthritis, Chondrocytes

Abstract

Objectives: The objective of this research was to compare the anti-inflammatory activity of aqueous and methanolic extracts of C. cassia (CC) and C. zeylanicum (CZ) in mouse macrophage (RAW264.7) and human chondrosarcoma (SW1353) cell lines as well as in human primary chondrocytes, to correlate their efficacy in management of osteoarthritis (OA) related pathophysiology.

Methods: RAW264.7, SW1353 and human primary chondrocytes were pre-treated with aqueous extracts of C. cassia (CCW) and C. zeylanicum (CZW) and methanolic extracts of C. cassia (CCM) and C. zeylanicum (CZM) at various concentrations (0.1-100 µg/ml) for 1 h, followed by stimulation with LPS and IL-1β, respectively. The effect of CCM, CCW, CZM and CZW on the production of nitric oxide (NO) was evaluated by Griess reaction. Evaluation of prostaglandin E2 (PGE2) and leukotriene (LTB4) proteins was performed by EIA-Monoclonal based kits. The effect of these extracts on matrix metalloproteinase (MMPs-2, 9 and 13) levels was analyzed by SensoLyte® fluorimetric MMP assay kit.

Results: The methanolic extracts (CCM, CZM) of both the varieties of cinnamon were found to be more effective than the aqueous extracts in terms of PGE2, LTB4 and MMP inhibition.

We found that in RAW 264.7, CCM and CZM decreased NO and PGE2 production by45.40%±8.6; 65.63%±5.7 and 79.88%±1.2; 95.91%±0.3, respectively. Similarly, in SW1353 and chondrocytes, CCM decreased PGE2 production by 68.8%±6.4;36.1%±9.5, respectively whereas CZM reduced PGE2 production by 70.2%±2.3; 52.3%±5.4, respectively. Moreover, in SW1353 and chondrocytes CCM decreased LTB4 production by 85.47%±3.03; 99.6%±0.2, respectively whereas CZM reduced LTB4 production by 67.5%±5.6; 75.6%±1.2, respectively. In chondrocytes both CCM and CZM significantly reduced the levels of MMP-2(55.7%±5.2; 73.1%±7.1), MMP-9 (57.5%±4.7; 74.5%±5.2) and MMP-13 (90.1%±2.6; 71.2%±12.5), respectively. However, on comparing the two species of cinnamon, C. zeylanicumwas found to be more effective than C. cassia andthus could be considered for its potential therapeutic application in the management of inflammatory conditions associated with OA.

Conclusion: The present study would help in choosing better of the two species of cinnamon for their possible therapeutic application in the management of inflammatory condition associated with OA.

 

Downloads

Download data is not yet available.

References

Balasubramanian S, Roselin P, Singh KK, Zachariah J, Saxena SN. Post harvest processing and benefits of black pepper, coriander, cinnamon, fenugreek and turmeric spices. Crit Rev Food Sci Nutr 2015. [Article in Press].

Rao PV, Gan SH. Cinnamon: a multifaceted medicinal plant. J Evidence Based Complementary Altern Med 2014. doi.org/10.1155/2014/642942. [Article in Press]

Hong JW, Yang GE, Kim YB, Eom SH, Lew JH, Kang H. Anti-inflammatory activity of cinnamon water extract in vivo and in vitro LPS-induced models. BMC Complementary Altern Med 2012;12:237.

Huang, Kee C. The pharmacology of Chinese herbs. Edn 2. Vol. I. CRC press: Florida; 1998.

Tanaka S, Yoon YH, Fukui H, Tabata M, Akira T, Okano K, et al. Antiulcerogenic compounds isolated from chinese cinnamon. Planta Med 1989;55:245-8.

Gunawardena D, Karunaweera N, Lee S, van Der Kooy F, Harman DG, Raju R, et al. Anti-inflammatory activity of cinnamon (C. zeylanicum and C. cassia) extracts-identification of E-cinnamaldehyde and o-methoxy cinnamaldehyde as the most potent bioactive compounds. Food Funct 2015;6:910-9.

Sini KR, Sinha BN, Karpakavalli M, Sangeetha PT. Analgesic and antipyretic activity of Cassia occidentalis Linn. Ann Biol Res 2011;2:195-200.

Ooi LS, Li Y, Kam SL, Wang H, Wong EY, Ooi VE. Antimicrobial activities of cinnamon oil and cinnamaldehyde from the Chinese medicinal herb Cinnamomum cassia Blume. Am J Chin Med 2006;34:511-22.

Wickenberg J, Lindstedt S, Nilsson J, Hlebowicz J. Cassia cinnamon does not change the insulin sensitivity or the liver enzymes in subjects with impaired glucose tolerance. Nutr J 2014;13:96.

Kwon HK, Hwang JS, So JS, Lee CG, Sahoo A, Ryu JH, et al. Cinnamon extract induces tumor cell death through inhibition of NFkappaB and AP1. BMC Cancer 2010;10:392.

Zhang C, Li C, Sui F, Lu Y, Li L, Guo S, et al. Cinnamaldehyde decreases interleukin-1beta induced PGE2 production by down-regulation of mPGES-1 and COX-2 expression in mouse macrophage RAW264.7 cells. Zhongguo Zhongyao Zazhi 2012;37:1274-8.

Liao JC, Deng JS, Chiu CS, Hou WC, Huang SS, Shie PH, et al. Anti-Inflammatory Activities of Cinnamomum cassia constituents in vitro and in vivo. J Evidence-Based Complementary Altern Med 2012. doi.org/10.1155/2012/429320. [Article in Press]

Ranasinghe P, Perera S, Gunatilake M, Abeywardene E, Gunapala N, Premakumara S, et al. Effects of Cinnamomum zeylanicum (Ceylon cinnamon) on blood glucose and lipids in a diabetic and healthy rat model. Pharmacogn Res 2012;4:73-9.

Zhang Y, Wang X, Ma L, Dong L, Zhang X, Chen J, et al. Anti-inflammatory, antinociceptive activity of an essential oil recipe consisting of the supercritical fluid CO2 extract of white pepper, long pepper, cinnamon, saffron and myrrh in vivo. J Oleo Sci 2014;63:1251-60.

Joshi K, Awte S, Bhatnagar P, Walunj S, Gupta R, Joshi SP. Cinnamomum zeylanicum extract inhibits proinflammatory cytokine TNFâˆ: in vitro and in vivo studies. Res Pharm Biotechnol 2010;2:14-21.

Vetala S, Bodhankara SL, Mohanb V, Thakurdesai PA. Anti-inflammatory and anti-arthritic activity of type-A procyanidine polyphenols from bark of Cinnamomum zeylanicum in rats. Food Sci Human Wellness 2013;2:59-67.

Gunawardena D, Karunaweera N, Lee S, van Der Kooy F, Harman DG, Raju R, et al. Anti-inflammatory activity of cinnamon (C. zeylanicum and C. cassia) extracts-identification of E-cinnamaldehyde and o-methoxy cinnamaldehyde as the most potent bioactive compounds. Food Funct 2015;6:910-9.

Hong JW, Yang GE, Kim YB, Eom SH, Lew JH, Kang H. Anti-inflammatory activity of cinnamon water extract in vivo and in vitro LPS-induced models. BMC Complement Altern Med 2012;12:237.

Thyagaraj VD, Koshy R, Kachroo M, Mayachari AS, Sawant LP, Balasubramanium M. A validated RP-HPLC-UV/DAD method for simultaneous quantitative determination of rosmarinic acid and eugenol in Ocimum sanctum L. Pharm Meth 2013;4:1-5.

Koppikar SJ, Choudhari AS, Suryavanshi SA, Kumari S, Chattopadhyay S, Kaul-Ghanekar R. Aqueous cinnamon extract (ACE-c) from the bark of Cinnamomum cassia causes apoptosis in human cervical cancer cell line (SiHa) through loss of mitochondrial membrane potential. BMC Cancer 2010;10:210.

Choudhari AS, Raina P, Deshpande MM, Wali AG, Zanwar A, Bodhankar SL, et al. Evaluating the anti-inflammatory potential of Tectaria cicutaria L. rhizome extract in vitro as well as in vivo. J Ethnopharmacol 2013;150:215-22.

Sharma JN, Al-Omran A, Parvathy SS. Role of nitric oxide in inflammatory diseases. Inflammopharmacol 2007;15:252-9.

Suantawee T, Tantavisut S, Adisakwattana S, Tanpowpong T, Tanavalee A, Yuktanandana P, et al. Upregulation of inducible nitric oxide synthase and nitrotyrosine expression in primary knee osteoarthritis. J Med Assoc Thailand 2015;98:S91-7.

Kumar AN, Bevara GB, Laxmikoteswramma K, Malla R. Antioxidant, cytoprotective and antiinflammatory activities of stem bark extract of Semecarpus Anacardium. Asian J Pharm Clin Res 2013;6:213-9.

Ho SC and Tsai PJ. Comparison of the Effects of Hot†and Cold†Chinese medicinal plants on the production of inflammatory mediators by RAW 2647 Cells. J Food Drug Anal 2004;12:2.

Attur M, Al-Mussawir HE, Patel J, Kitay A, Dave M, Palmer G, et al. Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for. signaling via the EP4 receptor. J Immunol 2008;81:5082-8.

Goldring MB, Berenbaum F. The regulation of chondrocyte function by proinflammatory mediators: prostaglandins and nitric oxide. Clin Orthop Relat Res 2004;427 Suppl:S37–S46.

Dave M, Attur M, Abramson SB. COX-2, NO and cartilage damage and repair. Curr Rheumatol Rep 2000;2:447-53.

Afonso PV, Janka-Junttila M, Lee YJ, McCann CP, Oliver CM, Aamer KA, et al. LTB4 is a signal-relay molecule during neutrophil chemotaxis. Dev Cell 2012;22:1079-91.

Monteiro APT, Pinheiro CS, Luna-Gomes T, Alves LR, Maya-Monteiro CM, Porto BN, et al. Leukotriene B4 mediates neutrophil migration induced by heme. J Immunol 2011;186:6562–7.

Sala A, Zarini S, Bolla A. Leukotrienes: Lipid bioeffectors of inflammatory reactions. Biochem 1988;63:84-92.

Crooks SW, Stockley RA. Leukotriene B4. Int J Biochem Cell Biol 1988;30:173-8.

Opdenakker G, Van den Steen PE, Van Damme J. Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol 2001;22:571-9.

Mengshol JA, Vincenti MP, Brinckerhoff CE. IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells: requirement for Runx-2 and activation by p38 MAPK and JNK pathways. Nucleic Acids Res 2001;29:4361-72.

D'Angelo M, Yan Z, Nooreyazdan M, Pacifici M, Sarment DS, Billings PC, et al. MMP-13 is induced during chondrocyte hypertrophy. J Cell Biochem 2000;77:678-93.

Wang YH, Avula B, Nanayakkara NP, Zhao J, Khan IA. Cassia cinnamon as a source of coumarin in cinnamon-flavored food and food supplements in the United States. J Agric Food Chem 2013;61:4470-6.

Published

01-11-2015

How to Cite

Raina, P., C. Chandrasekaran, A. Aggarwal, N. Wagh, and R. K. Ghanekar. “COMPARATIVE ANALYSIS OF ANTI-INFLAMMATORY ACTIVITY OF AQUEOUS AND METHANOLIC EXTRACTS OF C. CASSIA AND C. ZEYLANICUM IN RAW264.7, SW1353 AND PRIMARY CHONDROCYTES”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 7, no. 11, Nov. 2015, pp. 392-6, https://journals.innovareacademics.in/index.php/ijpps/article/view/8554.

Issue

Section

Short Communication(s)